Skip to main content
SpringerLink
Log in

Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients

Clinical aspects, psychophysiology, and drug plasma levels

  • Published:
European archives of psychiatry and neurological sciences Aims and scope Submit manuscript

Summary

Amitriptyline (AT) and the noradrenaline reuptake inhibiting antidepressant oxaprotiline (OT = hydroxymaprotiline) were compared in 59 primary depressive inpatients in a 4-week double blind parallel group design. In the Hamilton Depression Rating Scale and 2 self-rating scales AT proved to be more efficient than OT, mainly with respect to disturbances of appetite and sleep. Agitated patients receiving OT needed more additional tranquilizing medication. The number of side-effects did not differ. Both drugs increased heart rate and skin resistance level (SRL) to about the same degree and did not influence the number of spontaneous fluctuations of SRL, habituation of SRL orienting responses (OR), frequencies of respiration and blinking. Salivation was temporarily more impaired by AT. All physiological variables differed between patients and 30 healthy controls during the whole 4-week trial. Clinical outcome showed a linear relation to OT plasma levels. For AT a therapeutic window was confirmed for concentrations of AT and its metabolite nortriptyline between 125 and 200 ng/ml. Patients whose SRL-OR habituated rapidly had a better outcome than slow habituators. Urinary excretion of 3-methoxy-4-hydroxyphenylglycol was lower in patients than in controls but could not predict outcome with either drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bente D, Fähndrich E (1980) Clinical and EEG effects of hydroxymaprotiline in depressive patients with special reference to responders and non-responders. Arzneim-Forsch/Drug Res 30 (II):1227

    Google Scholar 

  • Breyer U, Villumsen K (1976) Plasma level measurement of tricyclic psychoactive drugs and their metabolites by UV reflectance photometry on thin layer chromatograms. Eur J Clin Pharmacol 9:457–465

    Google Scholar 

  • Breyer-Pfaff U, Gaertner HJ, Giedke H (1982) Plasma levels, psychophysiological variables, and clinical response to amitriptyline. Psychiatry Res 6:223–234

    Google Scholar 

  • Breyer-Pfaff U, Wiatr R, Nill K (1984) Measurement of maprotiline and oxaprotiline in plasma by high-performance liquid chromatography of fluorescent derivatives. J Chromatogr 309:107–114

    Google Scholar 

  • Brunswick D, Amsterdam J, Mendels J, Stern S (1979) Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data. Clin Pharmacol Ther 25:605–610

    Google Scholar 

  • Covi L, Rickets K, Lipman R, McNair D, Smith V, Downing R, Kahn R, Fisher S (1981) Effects of psychotropic agents on primary depression. Psychopharmacol Bull 17:100

    Google Scholar 

  • Delini-Stula A, Bischoff S, Radeke E (1982a) Antiserotoninergic properties of maprotiline and a new antidepressant, oxaprotiline: two selective NA uptake inhibitors. Drug Dev Res 2:543–550

    Google Scholar 

  • Delini-Stula A, Hauser K, Baumann P, Olpe HR, Waldmeier P, Storni A (1982b) Stereospecificity of behavioural and biochemical responses to oxaprotiline — a new antidepressant. In: Costa E, Racagni G (eds) Typical and atypical antidepressants. Adv Biochem Psychopharmacol 31:265–275

  • Feighner J, Brauzer B, Gelenberg A, Gomez E, Kiev A, Kurland M, Weiss B (1979) A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness. Psychopharmacology 61:217–225

    Google Scholar 

  • Feighner J, Roffman M, Dixon R (1981) An early clinical trial of oxaprotiline in hospitalized patients with primary depression. Curr Ther Res 29:363–369

    Google Scholar 

  • Frankenhaeuser M (1975) Experimental approaches to the study of catecholamines and emotion. In: Levi L (ed) Emotions. Raven Press, New York, pp 209–234

    Google Scholar 

  • Frith C, Stevens M, Johnstone E, Crow T (1979) Skin conductance responsivity during acute episodes of schizophrenia as a predictor of symptomatic improvement. Psychol Med 9:101–106

    Google Scholar 

  • Gaertner HJ, Wiatr G, Kuss HJ (1980) 4-Methoxy-3-hydroxyphenylglycol as an internal standard for the determination of 3methoxy-4-hydroxyphenylglycol in urine. Results obtained in depressed patients and healthy controls. J Clin Chem Clin Biochem 18:579–583

    Google Scholar 

  • Gaertner HJ, Golfinopoulos G, Breyer-Pfaff U (1982a) Response to maprotiline treatment in depressive patients. Relationship to urinary MHPG excretion and plasma drug level. Pharmacopsychiatry 15:170–174

    Google Scholar 

  • Gaertner HJ, Kreuter F, Scharek G, Wiatr G, Breyer-Pfaff U (1982b) Do urinary MHPG and plasma drug levels correlate with response to amitriptyline therapy? Psychopharmacology 76:236–239

    Google Scholar 

  • Giedke H (1983) Zur Psychophysiologie von Depression und Manic. In: Saletu B, Berner P (Hgb) Zyklothymie. Excerpta Medica, Amsterdam, pp 29–39

    Google Scholar 

  • Giedke H, Heimann H, Straube E (1982) Vergleichende Ergebnisse psychophysiologischer Untersuchungen bei Schizophrenien und Depressionen. In: Huber G (Hrsg) Endogene Psychosen: Diagnostik, Basissymptome und biologische Parameter. F. K. Schattauer, Stuttgart, New York, pp 295–312

    Google Scholar 

  • Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiat 23:56–62

    Google Scholar 

  • Heimann H (1979) Psychophysiologie endogener Psychosen. Schweiz Arch Neurol Neurochir Psychiatr 125:231–252

    Google Scholar 

  • Heimann H, Schmocker M, Straube E (1977) The psychophysiological basis of the pharmacotherapy of endogenous psychotics. In: Arieti S, Chrzanowski G (eds) New dimensions in psychiatry: a world view, vol 2, Wiley, New York, pp 363–374

    Google Scholar 

  • Iacono W, Lykken D, Peloquin L, Lumry A, Valentine R, Tuason V (1983) Electrodermal activity in euthymic unipolar and bipolar affective disorders. Arch Gen Psychiatry 40:557–565

    Google Scholar 

  • Iacono W, Lykken D, Haroian K, Peloquin L, Valentine R, Tuason V (1984) Electrodermal activity in euthymic patients with affective disorders: one-year retest stability and the effects of stimulus intensity and significance. J Abnorm Psychol 93:304–311

    Google Scholar 

  • Johnstone E, Owens D, Frith D, Mcpershon K, Dowie C, Riley G, Gold A (1980) Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychol Med 10:321–328

    Google Scholar 

  • Kielholz P (1973) Diagnose und Therapie der Depressionen für den Praktiker. Lehmann, München

    Google Scholar 

  • van der Kolk B, Shader R, Greenblatt D (1978) Autonomic effects of psychotropic drugs. In: Lipton M, DiMascio A, Killam K (eds) Psychopharmacology: A generation of progress. Raven Press, New York, pp 1009–1020

    Google Scholar 

  • Maas J, Fawcett J, Dekirmenjian H (1972) Catecholamine metabolism, depressive illness and drug response. Arch Gen Psychiat 26:252–262

    Google Scholar 

  • Madakasira S, Khazanie P, Sato T (1984) Single-dose single-point method in amitriptyline therapy. Psychopharmacology 84:574–576

    Google Scholar 

  • Maitre L, Moser P, Baumann P, Waldmeier P (1980) Amine uptake inhibitors: criteria of selectivity. In: Svensson T, Carlsson A (eds) Biogenic amines and affective disorders. Acta Psychiatr Scand 61, (Suppl 280): 97–110

  • Montgomery S, McAuley R, Rani S, Montgomery D, Braithwaite R, Dawling S (1979) Amitriptyline plasma concentration and clinical response. Br Med J 1:230

    Google Scholar 

  • Moyes ICA, Ray RL, Moyes RB (1980) Plasma levels and clinical improvement — a comparative study of clomipramine and amitriptyline in depression. Postgrad Med 156 (Suppl 1): 127–129

    Google Scholar 

  • Müller A, Binz U, Wendt G (1983) A double blind comparison: oxaprotiline and maprotiline. VII World Congress of Psychiatry, Vienna, Austria, July 11–16 (poster 687)

  • Preskorn SH, Leonard K, Hignite C (1980) Liquid chromatography of amitriptyline and related tricyclic compounds. J Chromatogr 197:246–250

    Google Scholar 

  • Redmond FC, Bowden CL, Lehmann LS, Stanton BC (1980) Single-dose prediction of amitriptyline and nortriptyline requirement in unipolar depression. Curr Ther Res 27:635–642

    Google Scholar 

  • Rickets K (1981) Limbitrol (amitriptyline plus chlordiazepoxide) revisited. Psychopharmacology 75:31–33

    Google Scholar 

  • Roffman M, Gould E (1982) Comparison of oxaprotiline to amitriptyline and placebo in depressed patients: relationship to MHPG. 13th CINP Congress, Jerusalem, Israel, June 20–25, Astracts vol II, p 624 (poster 47)

  • Roffman M, Gould E, Brewer S, Lau H, Sachais B, Dixon R, Kaczmarek L, LeSher A (1982) A double-blind comparative study of oxaprotiline with amitriptyline and placebo in moderate depression. Curr Ther Res 32:247–256

    Google Scholar 

  • Roffman M, Gould E, Brewer S, Lau H, Sachais B, Dixon N, Kaczmarek L, LeSher A (1983) Comparative anticholinergic activity of oxaprotiline and amitriptyline. Drug Dev Res 3:561–566

    Google Scholar 

  • SAS Institute (1982) SAS user's guide: statistics. Cary, North Carolina

  • Schatzberg J, Cole J (1978) Benzodiazepines in depressive disorders. Arch Gen Psychiatry 35:1359–1365

    Google Scholar 

  • Schildkraut J (1974) Biochemical criteria for classifying depressive disorders and predicting responses to pharmacotherapy: Preliminary findings from studies of norepinephrine metabolism. Pharmacopsychiatry 7:98–107

    Google Scholar 

  • Schmauss M, Laakmann G, Blaschke D, Büttermann M, Dieterle D, Kropp M (1980) Treatment of endogenous-depressed patients with hydroxymaprotiline — pilot study. Arzneim-Forsch/Drug Res 30 (II):1228–1229

    Google Scholar 

  • Schmidlin O, Gundert-Remy U, Mäurer W, Weber E (1982) Differences of sympathomimetic and anticholinergic action of OH-maprotiline and its R(−)-enantiomer. Br J Clin Pharmacol 14:799–804

    Google Scholar 

  • Schramm M, Selinger Z (1973) Operation of two epinephrine receptors and an acetylcholine receptor in the exocrine cell of the rat parotid gland. In: Usdin E, Snyder S (eds) Frontiers in catecholamine research. Pergamon Press, New York, pp 373–376

    Google Scholar 

  • Sigg E (1968) In: Efron D (ed) Psychopharmacology, review of progress, 1957–1967. U. S. Government Printing Office, Washington, DC, pp 581–588

    Google Scholar 

  • Spitzer R, Endicott J, Robins E (1978) Research Diagnostic Criteria. Arch Gen Psychiatry 35:773–782

    Google Scholar 

  • Szabadi E, Gaszner P, Bradshaw C (1980) The peripheral anticholinergic activity of tricyclic antidepressants: comparison of amitryptiline and desipramine in human volunteers. Br J Psychiatr 137:433–439

    Google Scholar 

  • Task Force on the Use of Laboratory Tests in Psychiatry (1985) Tricyclic antidepressants — blood level measurements and clinical outcome: an APA Task Force report. Am J Psychiatr 142:155–162

    Google Scholar 

  • Vandel B, Vandel S, Allers G, Bechtel P, Volmat R (1979) Interaction between amitriptyline and phenothiazine in man: Effect on plasma concentration of amitriptyline and its metabolite nortriptyline and the correlation with clinical response. Psychopharmacology 65:187–190

    Google Scholar 

  • Waldmeier P, Baumann P, Wilhelm M, Bernasconi R, Maitre L (1977) Selective inhibition of noradrenaline and serotonin uptake by C49802-B-Ba and CGP 6085 A. Eur J Pharmacol 46:387–391

    Google Scholar 

  • Wolfersdorf M, Binz U, Metzger R, Studemund B, Wendt G, Hole G (1983) Double-blind study: oxaprotiline vs clomipramine. VII World Congress of Psychiatry, Vienna, Austria, July 11–16 (poster 653)

  • Zahn T, Carpenter W, McGlashan T (1981) Autonomic nervous system activity in acute schizophrenia. II. Relationships to short-term prognosis and clinical state. Arch Gen Psychiatry 38:260–266

    Google Scholar 

  • von Zerssen D (1976) Klinische Selbstbeurteilungs-Skalen (KSb-S) aus dem Münchener Psychiatrischen Informationssystem (PSYCHIS München) Beltz Test Gesellschaft, Weinheim

Download references

Author information

Authors and Affiliations

  1. Psychiatrische Klinik der Universität, D-7400, Tübingen, Germany

    H. Giedke, H. Gaertner, W. Rein & D. Axmann

  2. Institut für Toxikologie der Universität, D-7400, Tübingen, Germany

    U. Breyer-Pfaff

Authors
  1. H. Giedke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Gaertner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Breyer-Pfaff
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Rein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Axmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giedke, H., Gaertner, H., Breyer-Pfaff, U. et al. Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Eur Arch Psychiatr Neurol Sci 235, 329–338 (1986). https://doi.org/10.1007/BF00381001

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00381001

Key words

Search

Navigation